Although the expressional regulation of its target genes such as DNMT1, DNMT3A and DNMT3B has been reported in breast cancer cells [35], one of its notable underlying mechanisms for the progression of malignancy is its binding with its target proteins and regulation of their activity. Here, DNMT1 is linked to breast carcinoma.